Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples

Por Renfro, L. A., Sargent, D. J.
Publicado no Ann Oncol (2017)

Multi-state models for colon cancer recurrence and death with a cured fraction

Por Conlon, A.S.C., Taylor, J.M.G., Sargent, D.J.
Publicado em 2013

Improving efficiency in clinical trials using auxiliary information; Application of a multi-state cure model

Por Conlon, A.S.C., Taylor, J.M.G., Sargent, D.J.
Publicado no Biometrics (2015)

Comment on: ‘Evaluation of chemoresponse assays as predictive markers'

Por Tian, C, Gabrin, M J, Brower, S L, Sargent, D J
Publicado no Br J Cancer (2015)

Baseline Quality of Life Is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer

Por Hubbard, J., Grothey, A., Campbell, M., Novotny, P., Sargent, D.J., Sloan, J., Goldberg, R.M.
Publicado em 2010

Validation of Novel Imaging Methodologies for use as Cancer Clinical Trial Endpoints

Por Sargent, D. J., Rubinstein, L., Schwartz, L., Dancey, J. E., Gatsonis, C., Dodd, L. E., Shankar, L. K.
Publicado em 2008

Model-based prediction of defective DNA mismatch repair using clinicopathological variables in sporadic colon cancer patients

Por Sinicrope, Frank, Foster, N.R., Sargent, D.J., Thibodeau, S.N., Smyrk, T.C., O'Connell, M.J.
Publicado em 2010

Evaluation of a chemoresponse assay as a predictive marker in the treatment of recurrent ovarian cancer: further analysis of a prospective study

Por Tian, C, Sargent, D J, Krivak, T C, Powell, M A, Gabrin, M J, Brower, S L, Coleman, R L
Publicado em 2014

Mapping QTL associated with Verticillium dahliae resistance in the cultivated strawberry (Fragaria × ananassa)

Por Antanaviciute, L, Šurbanovski, N, Harrison, N, McLeary, K J, Simpson, D W, Wilson, F, Sargent, D J, Harrison, R J
Publicado no Hortic Res (2015)

Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status

Por Rego, R L, Foster, N R, Smyrk, T C, Le, M, O'Connell, M J, Sargent, D J, Windschitl, H, Sinicrope, F A
Publicado em 2010

Innovative estimation of survival using log-normal survival modelling on ACCENT database

Por Chapman, J W, O'Callaghan, C J, Hu, N, Ding, K, Yothers, G A, Catalano, P J, Shi, Q, Gray, R G, O'Connell, M J, Sargent, D J
Publicado em 2013

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

Por Grothey, A., Sobrero, A.F., Shields, A.F., Yoshino, T., Paul, J., Taieb, J., Souglakos, J., Shi, Q., Kerr, R., Labianca, R., Meyerhardt, J.A., Vernerey, D., Yamanaka, T., Boukovinas, I., Meyers, J.P., Renfro, L.A., Niedzwiecki, D., Watanabe, T., Torri, V., Saunders, M., Sargent, D.J., Andre, T., Iveson, T.
Publicado no N Engl J Med (2018)

Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population(†)

Por Renfro, L. A., Grothey, A., Kerr, D., Haller, D. G., André, T., Van Cutsem, E., Saltz, L., Labianca, R., Loprinzi, C. L., Alberts, S. R., Schmoll, H., Twelves, C., Yothers, G., Sargent, D. J., Sargent, D.J., Green, E., Grothey, A., Alberts, S.R., Shi, Q., Renfro, L.A., Yothers, G., O'Connell, M.J., Wolmark, N., de Gramont, A., Gray, R., Kerr, D., Haller, D.G., Guthrie, K., Buyse, M., Labianca, R., Seitz, J.F., O'Callaghan, C.J., Francini, G., Catalano, P.J., Blanke, C.D., Andre, T., Goldberg, R.M., Benson, A., Twelves, C., Sirzen, F., Cisar, L., Van Cutsem, E., Saltz, L.
Publicado no Ann Oncol (2015)